Dabrafenib is a cancer medication that interferes with the growth and spread of cancer cells in the body. It is approved to treat melanoma. It is also being studied in the treatment of other types of cancers, including multiple myeloma.
| SparkCures ID | 113 |
|---|---|
| Developed By | GlaxoSmithKline |
| Generic Name | Dabrafenib |
| Additional Names | Tafinlar |
| Treatment Classifications |
|
There are no resources, links or videos to display for this treatment.